Oncologix Tech, Inc.
OCLG
$0.0001
$0.000.00%
OTC PK
| 05/31/2016 | 05/31/2015 | ||||
|---|---|---|---|---|---|
| Revenue | 813.20K | 1.24M | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 813.20K | 1.24M | |||
| Cost of Revenue | 554.20K | 885.60K | |||
| Gross Profit | 259.00K | 350.10K | |||
| SG&A Expenses | 349.90K | 443.90K | |||
| Depreciation & Amortization | 4.10K | 5.00K | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 908.30K | 1.33M | |||
| Operating Income | -95.10K | -98.90K | |||
| Income Before Tax | -264.30K | -525.40K | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -264.30K | -525.40K | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -264.30K | -525.40K | |||
| EBIT | -95.10K | -98.90K | |||
| EBITDA | -90.90K | -93.80K | |||
| EPS Basic | 0.00 | 0.00 | |||
| Normalized Basic EPS | 0.00 | 0.00 | |||
| EPS Diluted | 0.00 | 0.00 | |||
| Normalized Diluted EPS | 0.00 | 0.00 | |||
| Average Basic Shares Outstanding | 736.62M | 242.59M | |||
| Average Diluted Shares Outstanding | 736.62M | 242.59M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||